Valuation : REMSleep Holdings, Inc.

Market Cap 3.14M 2.7M 2.54M 2.32M 4.35M 297M 4.36M 30.05M 11.66M 152M 11.8M 11.54M 490M P/E 2024
-11.4x
P/E 2025 -0.88x
Enterprise Value 3.01M 2.59M 2.43M 2.22M 4.16M 284M 4.17M 28.75M 11.16M 146M 11.28M 11.04M 469M EV / Sales 2024
104,179,528x
EV / Sales 2025 157,471,623x
Free-Float
97.92%
Yield 2024 *
-
Yield 2025 -
1 day+14.01%
1 week-14.29%
Current month-5.76%
1 month+28.57%
3 months-40.00%
6 months-72.25%
Current year+5.88%
1 week 0
Extreme 0.0015
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.03
5 years 0
Extreme 0.0011
0.04
10 years 0
Extreme 0.0011
35
Manager TitleAgeSince
Chief Executive Officer - 2026-05-26
Treasurer 78 2026-05-26
President - 2026-06-01
Director TitleAgeSince
Director/Board Member 52 2026-03-01
Chairman 78 2026-05-26
Change 5-day change 1-year change 3-year change Capi.($)
+14.01%-14.29%-53.85%-90.58% 3.14M
-0.42%-3.68%-18.51%+7.39% 187B
+1.15%+3.22%+1.37%+17.42% 120B
-1.86%+2.77%+13.15%+91.44% 63.15B
-1.31%-1.09%+17.67%+43.65% 51.75B
-1.54%-2.52%-3.98%-32.30% 50.32B
-2.02%-3.22%+9.18%-12.39% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-15.78% 23.93B
-1.44%-4.21%-8.07%+11.30% 22.99B
Average +0.58%-1.73%-0.83%+2.24% 58.53B
Weighted average by Cap. -0.55%+0.02%-1.43%+16.92%

Financials

2024 2025
Net sales 0.12 0.1 0.09 0.09 0.16 11.06 0.16 1.12 0.44 5.68 0.44 0.43 18.29 0.02 0.01 0.01 0.01 0.02 1.58 0.02 0.16 0.06 0.81 0.06 0.06 2.61
Net income -1.08M -928K -873K -797K -1.49M -102M -1.5M -10.31M -4M -52.22M -4.05M -3.96M -168M -3.02M -2.6M -2.45M -2.23M -4.18M -285M -4.19M -28.9M -11.21M -146M -11.34M -11.09M -471M
Net Debt -438K -377K -354K -324K -606K -41.33M -607K -4.19M -1.63M -21.21M -1.64M -1.61M -68.32M -136K -117K -110K -101K -188K -12.85M -189K -1.3M -505K -6.59M -511K -500K -21.24M
Logo REMSleep Holdings, Inc.
REMSleep Holdings, Inc. is a medical device manufacturer. The Company’s focus is primarily on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. Its patented DeltaWave product is a nasal-pillow type interface that is designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. DeltaWave delivers comfort and airflow for better sleep and improved CPAP therapy. The Company’s product is manufactured by mold makers. It has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.
Employees
-
Date Price Change Volume
26-09-04 US$0.001750 +14.01% 1,745,769
26-09-03 US$0.001535 -12.29% 1,938,154
26-09-02 US$0.001750 -5.41% 974,599
26-09-01 US$0.001850 -3.14% 1,181,754
26-08-31 US$0.001910 -9.05% 1,856,966
  1. Stock Market
  2. Stocks
  3. RMSL Stock